The Oura IPO is drawing roughly four times the orders on offer as the smart-ring maker markets up to $2.2 billion in a U.S. listing, people familiar with the deal told reporters on September 26. Pricing is targeted for September 29, with shares expected to begin trading on the Nasdaq under the ticker OURA.
Part of our Tech, AI and Business coverage. Browse more in Science, Health and Culture.
Oura and selling stockholders are offering 50 million shares at a marketed range of $40 to $44, according to company filings and Reuters. At the top of that range, the sale implies about a $14.1 billion market capitalization on outstanding shares—or roughly $15–15.6 billion on a fully diluted basis.
How the Oura IPO is structured
Of the 50 million shares, Oura plans to sell 13.5 million while existing holders—including names such as Forerunner Ventures and Lifeline Ventures in coverage of the book—offer 36.5 million. Selling stockholders also intend to grant underwriters a 30-day option for up to 7.5 million more shares. Oura will not receive proceeds from shares sold by those stockholders.
Goldman Sachs, Morgan Stanley, and J.P. Morgan are lead underwriters, with Allen & Co. and Jefferies also listed among bookrunners in deal coverage. Banks expected to stop taking orders Monday afternoon, according to a September 26 Briefs report citing people familiar with the offering.
Demand, Lilly interest, and growth metrics
Reuters reported that Eli Lilly indicated interest in buying up to $100 million of shares, while Dragoneer signaled interest in up to $300 million. Orders totaling about four times the stock on offer put Oura among the strongest consumer-tech debuts in a fall window that has otherwise seen volatility and postponed listings.
An updated S-1 narrative says Oura now expects to end fiscal 2026 with about 5.7 million paid members—roughly 96 percent year-over-year growth—driven largely by Oura Ring 5 sales. The Finnish-founded company pitches the ring as a health-intelligence platform tracking sleep, heart metrics, and activity for consumers, teams, and research partners.
Why markets are watching wearable IPOs
Wearable and digital-health listings have been scarce at billion-dollar scale this year. Coverage noted Oura could be among the earliest 2026 deals above $1 billion to clear after other large IPOs slipped. A successful Nasdaq debut would also test how public investors value recurring membership revenue versus one-time hardware sales.
Competitors in rings, watches, and continuous monitoring will watch whether the Oura IPO prices at the top of the range and how shares trade after the open. Privacy and clinical-grade claims remain long-term diligence items for institutions that buy health-data platforms.
What happens the week of September 29
Retail investors will not get the same allocations as the institutions filling a four-times-covered book, but the marketing roadshow still spills into social feeds where Ring 5 owners compare waitlists and subscription tiers. That consumer buzz matters: wearable IPOs live or die on whether hardware cycles keep refreshing the paid-member funnel after the listing pop fades.
Regulatory risk is quieter but real. Any public wearable firm faces questions about health claims, data sharing with research partners, and how membership churn behaves if a rival watch or ring undercuts price. Oura’s S-1 growth story leans on Ring 5 momentum; sustaining 96 percent member growth into a public-market spotlight is a different test.
If the book holds, pricing on September 29 would set the stage for OURA’s first session on the Nasdaq Global Select Market. Terms can still change while discussions continue; spokespeople for Oura and Goldman Sachs declined comment in the Briefs report.
For consumers who already wear the ring to track recovery and sleep, the Oura IPO is less about ticker drama than whether a public company keeps shipping quieter hardware and stronger health insights. For Wall Street, it is a referendum on whether smart rings can carry a double-digit-billion valuation into 2027.
Related coverage: Brightline Bankruptcy Filing Aims to Cut Heavy Debt and Stock Market News: Nasdaq Tumbles as Big Tech Earnings Shake Investor Confidence.
Update: Oura postponed the IPO on Sept. 29, 2026, citing market uncertainty despite strong demand, according to Axios and CNBC.
Sources
- Yahoo Finance: Oura's IPO is about four times oversubscribed
- Axios: Smart-ring maker Oura delays $2 billion IPO
- CNBC: IPO postponements are accelerating in third quarter
Further Reading
Read next in Markets
Most read this week
- Abdul El-Sayed and the Muslim Brotherhood Claims: What’s Confirmed and What Isn’t
- Kremlin Names Abu Dhabi Team as Ukraine Sets Security and Prisoner Priorities
- Drones Kill Workers at Zaporizhzhia Nuclear and Thermal Plants, IAEA Says, as Russian Strikes Hit 5 Substations
- Fall Out Boy Will Play Fenway Park on July 30, 2027, With The Offspring, Good Charlotte and The Story So Far
- Nvidia Board Hires Wachtell’s Joon Kim to Lead Huang Probe as Shares Fall 5.47% and an Investor Sues
Latest
- Judge Lets Trump’s $10 Billion Defamation Suit Against the BBC Proceed
- Saudi Oil Output Hits Pre-War High as U.S. Gas Falls Below $4 a Gallon
- Nvidia Board Prepares to Oust Jensen Huang, WSJ Reports; Shares Drop 7% Late
- Congo’s Ebola Outbreak Tops 11,000 Cases as Kenya Discharges Its Last Patient
- Indonesia’s Vice President Gibran Offers to Resign Over Diploma Ruling
Get The Boston Report Briefing
Our free weekly email with the most important stories from Boston and the world. Unsubscribe anytime.
Free. We never sell your address. Privacy policy